Effect of canagliflozin on the disposition index, a marker of pancreatic beta-cell function, in type 2 diabetic patients: a randomized controlled study
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000030208
- Lead Sponsor
- Osaka University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Type 1 diabetes mellitus (2) Need insulin treatment (3) History of hypersensitivity to canagliflozin (4) Heart failure (NYHA class IV) (5) eGFR<45 mL/min/1.73 m2 (6) Severe hepatic dysfunction (7) Pregnancy, nursing or planning to become pregnant during the study (8) Suspected or diagnosed malignant tumors (9) Participating in another interventional study (10) Considered by a study physician to be inappropriate for any other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method